Attaining a correct diagnosis of COPD in general practice

Respiratory Medicine

Volumn 99, Issue 4, 2005, Pages 493-500

  Bolton, C E ^a   Ionescu, A A ^a   Edwards, P H ^b   Faulkner, T A ^b   Edwards, S M ^c   Shale, D J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Ely Bridge Surgery   (United Kingdom)

^c North Cardiff Medical Centre   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease (COPD); General practice; Spirometry

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LONG ACTING DRUG; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FORCED EXPIRATORY VOLUME; GENERAL PRACTICE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETER; SPIROMETRY; STAFF TRAINING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; EDUCATION, MEDICAL, CONTINUING; FAMILY PRACTICE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 14844297321     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.09.015     Document Type: Article

References (35)

1. Murray CJL, Lopez AD, Mathers CD, Stein C. The global burden of disease 2000 project: Aims, methods and data sources. Global programme on Evidence for Health Policy Discussion paper No. 36. World Health Organisation 2001
2. C.J.L. Murray A.D. Lopez The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors from 1990, and projected to 2020 1996 Harvard University Press Cambridge MA
3. S. Rennard M. Decramer P.M. Calverely N.B. Pride J.B. Soriano P.A. Vermeire J. Vestbo Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey Eur Respir J 20 4 2002 799-805
4. P.R.S. Tirimanna C.P. van Schayck J.J. den Otter C. van Weel C.L. van Herwaarden G. van den Boom et al. Prevalence of asthma and COPD in general practice in 1992: Has it changed since 1977? Br J Gen Pract 46 1996 277-281
5. D.S. Renwick M.J. Conolly Prevalence and treatment of chronic airways obstruction in adults over the age of 45 Thorax 51 1996 164-168
6. N.M. Siafakis P. Vermeire N.B. Pride P. Paoletti J. Gibson P. Howard et al. ERS-consensus statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD) Eur Respir J 8 1995 1398-1420
7. T.L. Petty Scope of the COPD problem in North America: Early studies of prevalence and NHANES III data: Basis for early identification and intervention Chest 117 5 Suppl 2 2000 326S-331S
8. B. Lundback A. Gulsvik M. Albers P. Bakke E. Ronmark G. van den Boom et al. Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Eur Respir J Suppl 40 2003 3s-9s
9. Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report, 2001. http://www.goldcopd.com
10. D. Bellamy G. Hoskins B. Smith F. Warner R. Neville For the General practitioners in Asthma group. The use of spirometers in general practice Asthma in General Practice 5 1997 8-9
11. Rudolf M on behalf of the COPD consortium. Making spirometry happen. Thorax 1999;54(suppl 3):A43
12. G. van den Boom M.P.M.H. van Rutten-Molken P.R.S. Tirimanna C.P. van Schayck H. Folgering C. Weel Association between health-related quality of life and consultation for respiratory symptoms: Results from the DIMCA programme Eur Respir J 11 1998 67-72
13. P.L. Enright R.O. Crapo Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers Clin Chest Med 21 2000 645-652
14. C.P. van Schayck F.M.M.A. van der Heijden G. van den Boom P.R.S. Tirimanna C.L.A. van Herwaarden Underdiagnosis of asthma: Is the doctor or the patient to blame? The DIMCA project Thorax 55 2000 562-565
15. COPD guidelines group of the standards of care committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(suppl 5):S1-28
16. NICE guidelines, http://www.nice.org.uk/pdf/ copd_fullguideline_2ndconsultation.pdf
17. GMS contract 2003. Investing in clinical practice. The NHS confederation, British Medical Association. http://www.bma.org.uk/ap.nsf/Content/NewGMSContract
18. L. Dow L. Fowler L. Phelps K. Waters D. Coggon A.L. Kinmonth S.T. Holgate Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK Thorax 56 2001 472-476
19. C. Griffiths G. Feder J. Wedzicha G. Foster A. Livingstone G.S. Marlowe Feasibility of spirometry and reversibility testing for the identification of patients with chronic obstructive pulmonary disease on asthma registers in general practice Respir Med 93 12 1999 903-908
20. C.E. McEvoy K.E. Ensrud E. Bender H.K. Genant W. Yu J.M. Griffith D.E. Niewoehner Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 3 1998 704-709
21. A.A. Eid A.A. Ionescu L.S. Nixon V. Lewis-Jenkins S.B. Matthews T.L. Griffiths D.J. Shale Inflammatory response and body composition in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1414-1418
22. E.F.M. Wouters A.M.W.J. Schols Prevalence and pathophysiology of nutritional depletion in chronic obstructive pulmonary disease Respir Med 87 suppl B 1993 45-47
23. H. Jackson R. Hubbard Detecting chronic obstructive pulmonary disease using peak flow rate: Cross sectional survey Br Med J 327 2003 653-654
24. C. Fletcher R. Peto The natural history of chronic airflow obstruction Br Med J 1 1977 1645-1648
25. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxaemic chronic obstructive lung disease: A clinical trial. Ann Intern Med 1980;93:391-8
26. Report of the Medical Research Council Working Party. Long term domicillary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-6
27. Calverley PMA, Burge PS, Spencer S, et al. for the ISOLD study investigators. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58:659-64
28. P.L. Enright K.C. Beck D.L. Sherrill Repeatability of spirometry in 18,000 adult patients Am J Respir Crit Care Med 169 2004 235-238
29. P.L. Brand P.H. Quanjer D.S. Postma H.A. Kerstjens G.H. Koeter P.A. Dekhuijzen H.J. Sluiter Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch chronic Non-specific lung disease (CNSLD) study group Thorax 47 1992 429-436
30. http://www.wales.gov.uk/kevpubstatisticsforwales/content/publication/ health/2001/sb25-2001.doc
31. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Topical Review. Guidelines for the measurement of respiratory function. Respir Med 1994;88:165-94
32. http://www.statistics.gov.uk/census2001/profiles/w.asp
33. Halpin DMG, Hart E, Harris T, Harbour R, Rudolf M on behalf of the BTS COPD consortium. What do General practice records tell us about the current management of COPD and the impact of the BTS COPD guidelines. Thorax 2000;55(Suppl 3):A38
34. T.R. Schermer J.E. Jacobs N.H. Chavannes J. Hartman H.T. Folgering B.J. Bottema C. van Weel Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) Thorax 58 2003 861-866
35. T. Eaton S. Withy J.E. Garrett J. Mercer R.M.L. Whitlock H.H. Rea Spirometry in primary care practice. The importance of quality assurance and the impact of spirometry workshops Chest 116 1999 416-423